Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin sodium Warfarin sodium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||
| 2 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin potassium Warfarin potassium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||
| 3 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin Warfarin 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬1. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||
| 4 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 [10] 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬4. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||
| 5 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F2 [1] F2 💬Complement and coagulation cascades
|
Dabigatran Dabigatran 💬Complement and coagulation cascades
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬5. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||
| 6 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
F2 [1] F2 💬Coronavirus disease
|
Dabigatran Dabigatran 💬Coronavirus disease
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬6. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||
| 7 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin sodium Warfarin sodium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||
| 8 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin potassium Warfarin potassium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||
| 9 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin Warfarin 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬7. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||
| 10 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin sodium Warfarin sodium 💬Hepatocellular carcinoma
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||
| 11 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin potassium Warfarin potassium 💬Hepatocellular carcinoma
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||
| 12 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin Warfarin 💬Hepatocellular carcinoma
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬10. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||
| 13 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
F2 [1] F2 💬Neuroactive ligand-receptor interaction
|
Dabigatran Dabigatran 💬Neuroactive ligand-receptor interaction
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬13. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||
| 14 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
F2 [1] F2 💬Pathogenic Escherichia coli infection
|
Dabigatran Dabigatran 💬Pathogenic Escherichia coli infection
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬14. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||
| 15 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
F2 [1] F2 💬Pathways in cancer
|
Dabigatran Dabigatran 💬Pathways in cancer
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬15. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
| 16 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin sodium Warfarin sodium 💬Pathways in cancer
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
| 17 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin potassium Warfarin potassium 💬Pathways in cancer
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
| 18 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin Warfarin 💬Pathways in cancer
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||
| 19 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
F2 [1] F2 💬Phospholipase D signaling pathway
|
Dabigatran Dabigatran 💬Phospholipase D signaling pathway
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬19. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||
| 20 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
F2 [1] F2 💬Platelet activation
|
Dabigatran Dabigatran 💬Platelet activation
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬20. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||
| 21 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
F2 [1] F2 💬Regulation of actin cytoskeleton
|
Dabigatran Dabigatran 💬Regulation of actin cytoskeleton
| Dabigatran | 051 [5] 51, 75, 85, 91, 124 💬21. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin sodium Warfarin sodium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin potassium Warfarin potassium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 2 drugs (DrugBank) and 17 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [15] 6 , 8 , 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬22. Ubiquinone and other terpenoid-quinone biosynthesis
|
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Ubiquinone and other terpenoid-quinone biosynthesis
3 genes, 2 drugs (DrugBank) and 17 diseases
